Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Obstet Gynaecol Can ; 32(10): 984-7, 2010 Oct.
Article in English | MEDLINE | ID: mdl-21176309

ABSTRACT

BACKGROUND: The management of a patient refusing blood transfusion who subsequently experiences a severe postpartum hemorrhage is a particular clinical challenge. CASE: A 30-year-old nulliparous patient (who was a Jehovah's Witness) had labour induced for post-dates at 41+4 weeks' gestational age after an uncomplicated pregnancy. She delivered by Caesarean section for dystocia and suspected chorioamnionitis, and subsequently developed postpartum hemorrhage that required management with oxytocin, ergometrine, carboprost, uterine artery ligation, and Hayman compression sutures. The patient ultimately required two additional visits to the operating room, culminating in hysterectomy. Use of tranexamic acid, recombinant factor VIIa, and Tisseel was instrumental in halting the ongoing hemorrhage. CONCLUSION: Optimal management of a patient refusing administration of blood products requires a multidisciplinary approach as well as a combination of traditional and novel therapies.


Subject(s)
Factor VIIa/therapeutic use , Fibrin Tissue Adhesive/therapeutic use , Hemostatics/therapeutic use , Jehovah's Witnesses , Postpartum Hemorrhage/therapy , Tranexamic Acid/therapeutic use , Adult , Antifibrinolytic Agents/therapeutic use , Female , Humans , Hysterectomy , Pregnancy , Recombinant Proteins/therapeutic use , Uterine Artery/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...